Earnings Feed
Start Free
Home/Insiders/Singleton Mark Leonard
SM
SEC Insider//CIK 0001914936

Singleton Mark Leonard

CIK 00019149361 companyDURHAM, NC
SEC Profile

Transactions

48

Companies

1

Filings

8

CIK

0001914936

Recent Transactions

48 trades
  • Tax Payment
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-03-20$8.64/sh−8,091→ 169,981 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-03-20+18,625→ 178,072 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-03-20−18,625→ 0 total
  • Tax Payment
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-03-13$8.62/sh−5,865→ 159,447 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2026-03-13+116,000→ 116,000 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-03-13+104,000→ 104,000 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-03-13+13,500→ 165,312 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-03-13−13,500→ 40,500 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-02-15+20,153→ 161,241 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-02-15−20,153→ 40,304 total
  • Tax Payment
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-02-15$8.27/sh−9,429→ 151,812 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-04-11$7.57/sh−3,875→ 141,088 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-04-10+13,000→ 144,963 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-04-10−13,000→ 26,000 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-03-24$9.79/sh−5,479→ 131,963 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-03-21−18,625→ 18,625 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-03-21+18,625→ 137,442 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-03-14+54,000→ 54,000 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2025-03-14+61,000→ 61,000 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-02-18$10.19/sh−6,498→ 118,817 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-02-15−20,153→ 60,457 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-02-15+20,153→ 125,315 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-12-23$10.53/sh−10,733→ 105,162 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-12-20−31,000→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-12-20+31,000→ 115,895 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-21$5.57/sh−9,219→ 84,895 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-20+31,000→ 94,114 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-20−31,000→ 31,000 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-17$5.84/sh−13,753→ 63,114 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-15+42,202→ 76,867 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-15−42,202→ 0 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-04-11$4.75/sh−4,000→ 34,665 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-04-10−13,000→ 39,000 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-04-10+13,000→ 38,665 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-03-22$5.39/sh−5,541→ 25,665 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-03-21+18,625→ 31,206 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-21−18,625→ 37,250 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2024-03-15+181,980→ 181,980 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-15+42,202→ 42,202 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-15+80,610→ 80,610 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-06-20+62,000→ 62,000 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-04-10+52,000→ 52,000 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2023-04-10+135,800→ 135,800 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2023-03-24$1.27/sh−6,044→ 12,581 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2023-03-21+18,625→ 18,625 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-03-21−18,625→ 55,875 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-04-04+74,500→ 74,500 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2022-04-04+223,200→ 223,200 total

Companies

1

Recent Filings

8

Address

4721 EMPEROR BOULEVARD, SUITE 100

DURHAM, NC, 27703

View on SEC.gov